Deep Learning In Drug Discovery And Diagnostics Global Market Report 2024

Description

Deep learning in drug discovery and diagnostics involves utilizing advanced neural networks and artificial intelligence (AI) to interpret complex biological and chemical data, allowing for the prediction of drug interactions, identification of disease patterns, and advancement of personalized medicine. This approach enhances drug discovery and diagnostics by increasing prediction accuracy, automating data processing, and facilitating personalized treatments through sophisticated data analysis.

Key applications of deep learning in this field include drug discovery, diagnostics, forensic interventions, and more. In drug discovery, deep learning algorithms analyze biological data to predict the effectiveness of drug compounds, accelerating the identification of potential candidates and side effects earlier in the research process. These drugs include small molecules and biologics, with end-use industries ranging from pharmaceutical and biotechnology companies to contract research organizations (CROs) and healthcare information technology (IT).

The deep learning in drug discovery and diagnostics market research report is one of a series of new reports from The Business Research Company that provides deep learning in drug discovery and diagnostics market statistics, including deep learning in drug discovery and diagnostics industry global market size, regional shares, competitors with a deep learning in drug discovery and diagnostics market share, detailed deep learning in drug discovery and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the deep learning in drug discovery and diagnostics industry. This deep learning in drug discovery and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The deep learning in drug discovery and diagnostics market size has grown exponentially in recent years. It will grow from $6.39 billion in 2023 to $8.21 billion in 2024 at a compound annual growth rate (CAGR) of 28.5%. The growth during the historic period can be credited to heightened investment in AI research, rising demand for personalized medicine, increased public and private funding, a surge in chronic diseases and complex conditions, and the growing use of electronic health records.

The deep learning in drug discovery and diagnostics market size is expected to see exponential growth in the next few years. It will grow to $22.45 billion in 2028 at a compound annual growth rate (CAGR) of 28.6%. The growth in the forecast period is expected to be driven by improved diagnostic accuracy, greater collaboration between tech companies and pharmaceutical firms, advancements in explainable AI (XAI) for enhanced model transparency, a stronger focus on real-world evidence (RWE), and expansion into emerging markets. Key trends in the forecast period include the adoption of AI technologies, enhanced computational power, integration of big data, development of new deep learning architectures, and the growth of cloud-based AI platforms.

The increasing demand for personalized medicine is expected to drive the growth of the deep learning market in drug discovery and diagnostics. Personalized medicine customizes treatment and interventions based on an individual's genetic, environmental, and lifestyle factors to improve effectiveness and reduce side effects. This demand is fueled by advancements in genomics and data analytics, which allow for more precise treatments tailored to individual patient profiles. Deep learning enhances personalized medicine by analyzing complex biological data to discover unique biomarkers and predict patient responses more accurately. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. This growing interest in personalized medicine is driving the expansion of deep learning in drug discovery and diagnostics.

Key players in the deep learning drug discovery and diagnostics market are focusing on advancing high-performance computing technologies, such as supercomputers, to boost innovation through enhanced performance and efficiency in complex tasks and AI applications. Improvements in supercomputers facilitate deep learning by accelerating complex data analysis and simulations, which helps in identifying drug candidates more quickly and improving diagnostic accuracy. For instance, in November 2022, Hewlett-Packard Enterprise, a US-based IT company, launched the HPE Cray EX and HPE Cray XD supercomputers. These systems offer powerful performance and scalable AI capabilities in a more compact and cost-effective design, aimed at expediting drug discovery and disease treatment. They enable researchers and pharmaceutical labs to gain deeper insights into chemical interactions, which promotes the development of new therapies for both challenging and emerging diseases.

In February 2024, Ginkgo Bioworks Holdings Inc., a US-based biotech company specializing in genetic engineering, acquired key assets from Reverie Labs for an undisclosed sum. This acquisition includes Reverie's infrastructure and software for training large-scale AI foundation models, which Ginkgo intends to leverage to enhance its AI and machine learning (ML)-driven discovery services and accelerate the development of next-generation biological foundation models. Reverie Labs Inc. is a US-based company that has developed and utilized AI and ML tools to expedite drug discovery.

Major companies operating in the deep learning in drug discovery and diagnostics market are Google Inc., Microsoft Corporation, International Business Machines Corporation, NVIDIA Corporation, Zebra Medical Vision Ltd, Tempus Labs Inc., Nanostring Technologies Inc., Owkin Inc., Insilico Medicine Inc., SOPHiA GENETICS SA, Qureai Technologies Pvt Ltd, H2Oai Inc., Arterys Inc., Deep Genomics Inc., GNS Healthcare Inc., MedAware Systems Inc., PathAI Inc., Kheiron Medical Technologies Ltd, CureMetrix Inc., OncoImmunity AS, Proscia Inc., BenevolentAI Ltd, BioXcel Therapeutics Inc.

North America was the largest region in the deep learning in drug discovery and diagnostics market in 2023. The regions covered in the deep learning in drug discovery and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the deep learning in drug discovery and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The deep learning in drug discovery and diagnostics market consists of revenues earned by entities by providing services such as developing and integrating deep learning algorithms, analyzing large-scale biological and chemical data, offering software solutions and platforms, and consulting on AI-driven drug discovery and diagnostic strategies. The market value includes the value of related goods sold by the service provider or included within the service offering. The deep learning in drug discovery and diagnostics market also includes sales of software platforms and tools, machine learning frameworks, data analytics solutions, cloud-based computing services, hardware accelerators, and AI-driven diagnostic devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Deep Learning In Drug Discovery And Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on deep learning in drug discovery and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for deep learning in drug discovery and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The deep learning in drug discovery and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Drug Discovery; Diagnostics; Forensic Interventions; Other Types
2) By Drug Type: Small Molecule Drugs; Biologics Drugs
3) By End Use Industry: Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations (CROs); Healthcare Information Technology (IT)
Companies Mentioned: Google Inc.; Microsoft Corporation; International Business Machines Corporation; NVIDIA Corporation; Zebra Medical Vision Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20549

1. Executive Summary

2. Deep Learning In Drug Discovery And Diagnostics Market Characteristics

3. Deep Learning In Drug Discovery And Diagnostics Market Trends And Strategies

4. Deep Learning In Drug Discovery And Diagnostics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Deep Learning In Drug Discovery And Diagnostics Market Size and Growth

5.1. Global Deep Learning In Drug Discovery And Diagnostics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Deep Learning In Drug Discovery And Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Deep Learning In Drug Discovery And Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Deep Learning In Drug Discovery And Diagnostics Market Segmentation

6.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Discovery
Diagnostics
Forensic Interventions
Other Types
6.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Small Molecule Drugs
Biologics Drugs
6.3. Global Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations (CROs)
Healthcare Information Technology (IT)

7. Deep Learning In Drug Discovery And Diagnostics Market Regional And Country Analysis

7.1. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Deep Learning In Drug Discovery And Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market

8.1. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Deep Learning In Drug Discovery And Diagnostics Market

9.1. China Deep Learning In Drug Discovery And Diagnostics Market Overview
9.2. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Deep Learning In Drug Discovery And Diagnostics Market

10.1. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Deep Learning In Drug Discovery And Diagnostics Market

11.1. Japan Deep Learning In Drug Discovery And Diagnostics Market Overview
11.2. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Deep Learning In Drug Discovery And Diagnostics Market

12.1. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Deep Learning In Drug Discovery And Diagnostics Market

13.1. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Deep Learning In Drug Discovery And Diagnostics Market

14.1. South Korea Deep Learning In Drug Discovery And Diagnostics Market Overview
14.2. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Deep Learning In Drug Discovery And Diagnostics Market

15.1. Western Europe Deep Learning In Drug Discovery And Diagnostics Market Overview
15.2. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Deep Learning In Drug Discovery And Diagnostics Market

16.1. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Deep Learning In Drug Discovery And Diagnostics Market

17.1. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Deep Learning In Drug Discovery And Diagnostics Market

18.1. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Deep Learning In Drug Discovery And Diagnostics Market

19.1. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Deep Learning In Drug Discovery And Diagnostics Market

20.1. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market

21.1. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market Overview
21.2. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Deep Learning In Drug Discovery And Diagnostics Market

22.1. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Deep Learning In Drug Discovery And Diagnostics Market

23.1. North America Deep Learning In Drug Discovery And Diagnostics Market Overview
23.2. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Deep Learning In Drug Discovery And Diagnostics Market

24.1. USA Deep Learning In Drug Discovery And Diagnostics Market Overview
24.2. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Deep Learning In Drug Discovery And Diagnostics Market

25.1. Canada Deep Learning In Drug Discovery And Diagnostics Market Overview
25.2. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Deep Learning In Drug Discovery And Diagnostics Market

26.1. South America Deep Learning In Drug Discovery And Diagnostics Market Overview
26.2. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Deep Learning In Drug Discovery And Diagnostics Market

27.1. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Deep Learning In Drug Discovery And Diagnostics Market

28.1. Middle East Deep Learning In Drug Discovery And Diagnostics Market Overview
28.2. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Deep Learning In Drug Discovery And Diagnostics Market

29.1. Africa Deep Learning In Drug Discovery And Diagnostics Market Overview
29.2. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Deep Learning In Drug Discovery And Diagnostics Market, Segmentation By End Use Industry, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape And Company Profiles

30.1. Deep Learning In Drug Discovery And Diagnostics Market Competitive Landscape
30.2. Deep Learning In Drug Discovery And Diagnostics Market Company Profiles
- 30.2.1. Google Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Microsoft Corporation
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. International Business Machines Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. NVIDIA Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Zebra Medical Vision Ltd
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Deep Learning In Drug Discovery And Diagnostics Market Other Major And Innovative Companies

31.1. Tempus Labs Inc.
31.2. Nanostring Technologies Inc.
31.3. Owkin Inc.
31.4. Insilico Medicine Inc.
31.5. SOPHiA GENETICS SA
31.6. Qureai Technologies Pvt Ltd
31.7. H2Oai Inc.
31.8. Arterys Inc.
31.9. Deep Genomics Inc.
31.10. GNS Healthcare Inc.
31.11. MedAware Systems Inc.
31.12. PathAI Inc.
31.13. Kheiron Medical Technologies Ltd
31.14. CureMetrix Inc.
31.15. OncoImmunity AS

32. Global Deep Learning In Drug Discovery And Diagnostics Market Competitive Benchmarking

33. Global Deep Learning In Drug Discovery And Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Deep Learning In Drug Discovery And Diagnostics Market

35. Deep Learning In Drug Discovery And Diagnostics Market Future Outlook and Potential Analysis

35.1 Deep Learning In Drug Discovery And Diagnostics Market In 2028 - Countries Offering Most New Opportunities
35.2 Deep Learning In Drug Discovery And Diagnostics Market In 2028 - Segments Offering Most New Opportunities
35.3 Deep Learning In Drug Discovery And Diagnostics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer